⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57127 | 0.83 | ALDH1A1 (0.35) | — | |
| Ethylene Glycol SCHEMBL6129571 | 0.77 | ALDH1A1 (0.31) | — | |
| SCHEMBL7450423 | 0.76 | — | — | |
| SCHEMBL5775012 | 0.74 | — | — | |
| Cyclohexene SCHEMBL1986964 | 0.72 | — | — | |
| SCHEMBL3622179 | 0.69 | ALDH1A1 (0.45) | — | |
| Benzamide SCHEMBL1205193 | 0.69 | L3MBTL1 (0.50) | — | |
| SCHEMBL23042847 | 0.68 | — | — | |
| Cyclopentene SCHEMBL8157049 | 0.68 | — | — | |
| Propionic Acid SCHEMBL4983364 | 0.66 | FFAR3 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030057-B2 | Oligonucleotide encoded chemical libraries | Plexium, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20230234065-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES | Plexium, Inc. | 2023-07-27 | — | — | US | disclosed |
| US-20230065224-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES, RELATED SYSTEMS, DEVICES, AND METHODS FOR DETECTING, ANALYZING, QUANTIFYING, AND TESTING BIOLOGICS/GENETICS | PLEXIUM INC (US) | 2023-03-02 | — | — | US | disclosed |
| US-11577249-B2 | Oligonucleotide encoded chemical libraries | Plexium, Inc. (US) | 2023-02-14 | — | — | US | disclosed |
| EP-4097232-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES, RELATED SYSTEMS, DEVICES, AND METHODS FOR DETECTING, ANALYZING, QUANTIFYING, AND TESTING BIOLOGICS/GENETICS | Plexium, Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| US-20220025358-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES | Plexium, Inc. | 2022-01-27 | — | — | US | disclosed |
| US-20210394178-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES | Plexium, Inc. | 2021-12-23 | — | — | US | disclosed |
| US-11084037-B2 | Oligonucleotide encoded chemical libraries | Plexium, Inc. (US) | 2021-08-10 | — | — | US | disclosed |
| WO-2021155040-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES, RELATED SYSTEMS, DEVICES, AND METHODS FOR DETECTING, ANALYZING, QUANTIFYING, AND TESTING BIOLOGICS/GENETICS | Plexium, Inc. (US) | 2021-08-05 | — | — | WO | disclosed |
| US-10981170-B2 | Oligonucleotide encoded chemical libraries | Plexium, Inc. (US) | 2021-04-20 | — | — | US | disclosed |
| EP-3687687-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES | Plexium, Inc. (US) | 2020-08-05 | — | — | EP | disclosed |
| EP-3622968-A1 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | The General Hospital Corporation (US) | 2020-03-18 | — | — | EP | disclosed |
| EP-2361098-B1 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | MASSACHUSETTS GEN HOSPITAL (US) | 2019-08-28 | — | — | EP | disclosed |
| US-20190210018-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES | Plexium, Inc. (US) | 2019-07-11 | — | — | US | disclosed |
| US-20190093103-A1 | OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES | Plexium, Inc. (US) | 2019-03-28 | — | — | US | disclosed |
| US-8900549-B2 | Compositions and methods for delivering a substance to a biological target | THE GENERAL HOSPITAL CORPORATION (US) | 2014-12-02 | — | — | US | disclosed |
| US-20130302246-A1 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | THE GENERAL HOSPITAL CORPORATION | 2013-11-14 | — | — | US | disclosed |
| US-20110268654-A1 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | THE GENERAL HOSPITAL CORPORATION (US) | 2011-11-03 | — | — | US | disclosed |
| EP-2361098-A2 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | The General Hospital Corporation (US) | 2011-08-31 | — | — | EP | disclosed |
| WO-2010051530-A2 | COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET | THE GENERAL HOSPITAL CORPORATION (US) | 2010-05-06 | — | — | WO | disclosed |